Sanjeev Anand1, Keyur Buch. 1. Department of Orthopaedic Surgery, Royal Oldham Hospital, Oldham, UK. sanjeevanand65@hotmail.com
Abstract
INTRODUCTION: The aim of this study was to audit referral rates for post-discharge symptomatic thromboembolic events following hip fracture surgery to assess the extent of the clinical problem and to initiate discussion on prolonged chemoprophylaxis. PATIENTS AND METHODS: All patients who underwent surgery for proximal hip fractures in one year (2001-2002) were followed up. Patient case-notes were used to identify all morbidity episodes within 3 months following discharge. Patients with suspected symptomatic thromboembolic episodes were investigated to confirm the diagnoses objectively. Reasons for hospital readmission and causes of death were identified. RESULTS: A total of 267 patients who underwent surgery for proximal hip fractures were included in the study. Forty-three patients died during initial admission episode. Of the 224 patients discharged, 46 (20.54%) patients were referred back to hospital within 3 months, for unplanned emergency management. Of these, 8 patients (3.57%) were referred back for suspected thromboembolic events. Of these, 6 (2.67%) were referred with a clinical diagnoses of deep vein thrombosis (DVT) but only 1 patient (0.45%) was confirmed to have DVT. Two patients (0.89%) were referred with features of pulmonary embolism (PE). Both were confirmed on ventilation-perfusion scans and both patients died. One patient died following PE in the community.Thus, overall, 3 deaths (1.34%) following discharge were recorded to be due to pulmonary embolism. CONCLUSIONS: Suspected thromboembolic events constitute a major proportion of unplanned referrals back to the hospital. Three deaths due to delayed pulmonary embolism may justify prolonged universal chemoprophylaxis following hip fracture surgery.
INTRODUCTION: The aim of this study was to audit referral rates for post-discharge symptomatic thromboembolic events following hip fracture surgery to assess the extent of the clinical problem and to initiate discussion on prolonged chemoprophylaxis. PATIENTS AND METHODS: All patients who underwent surgery for proximal hip fractures in one year (2001-2002) were followed up. Patient case-notes were used to identify all morbidity episodes within 3 months following discharge. Patients with suspected symptomatic thromboembolic episodes were investigated to confirm the diagnoses objectively. Reasons for hospital readmission and causes of death were identified. RESULTS: A total of 267 patients who underwent surgery for proximal hip fractures were included in the study. Forty-three patients died during initial admission episode. Of the 224 patients discharged, 46 (20.54%) patients were referred back to hospital within 3 months, for unplanned emergency management. Of these, 8 patients (3.57%) were referred back for suspected thromboembolic events. Of these, 6 (2.67%) were referred with a clinical diagnoses of deep vein thrombosis (DVT) but only 1 patient (0.45%) was confirmed to have DVT. Two patients (0.89%) were referred with features of pulmonary embolism (PE). Both were confirmed on ventilation-perfusion scans and both patients died. One patient died following PE in the community.Thus, overall, 3 deaths (1.34%) following discharge were recorded to be due to pulmonary embolism. CONCLUSIONS: Suspected thromboembolic events constitute a major proportion of unplanned referrals back to the hospital. Three deaths due to delayed pulmonary embolism may justify prolonged universal chemoprophylaxis following hip fracture surgery.
Authors: P C Comp; T E Spiro; R J Friedman; T L Whitsett; G J Johnson; G A Gardiner; G C Landon; M Jové Journal: J Bone Joint Surg Am Date: 2001-03 Impact factor: 5.284
Authors: William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray Journal: Chest Date: 2004-09 Impact factor: 9.410
Authors: Vasanth Sathiyakumar; Sarah E Greenberg; Alex A Jahangir; Hassan H Mir; William T Obremskey; Manish K Sethi Journal: Int Orthop Date: 2015-07-09 Impact factor: 3.075
Authors: Joao Torres; Manuel Gutierres; M Ascenção Lopes; J Domingos Santos; A T Cabral; R Pinto; Carola van Eck Journal: Biomed Res Int Date: 2014-05-14 Impact factor: 3.411
Authors: Edoardo Colzani; Mark Clements; Anna L V Johansson; Annelie Liljegren; Wei He; Judith Brand; Jan Adolfsson; Tommy Fornander; Per Hall; Kamila Czene Journal: Br J Cancer Date: 2016-10-04 Impact factor: 7.640
Authors: Kristen B Pitzul; Sarah E P Munce; Laure Perrier; Lauren Beaupre; Suzanne N Morin; Rhona McGlasson; Susan B Jaglal Journal: BMJ Open Date: 2017-03-21 Impact factor: 2.692